NMD3P2

Across TCGA pan-cancer cohorts, NMD3P2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated NMD3P2 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher NMD3P2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated NMD3P2 expression acts as an unfavorable survival marker, although some lineages such as COAD and TGCT show a favorable association.

KIRP, SARC, and READ are the cancer types where NMD3P2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.660	0.893	.003	42	view →
SARC	DFS	Tertile	All	0.184	0.525	.001	36	view →
READ	OS	Tertile	IV	0.644	0.899	.019	27	view →
SKCM	DFS	Tertile	IV	0.036	0.433	<.001	24	view →
HNSC	OS	Tertile	II,III,IV	0.122	0.406	.015	15	view →
COAD	OS	Tertile	All	0.905	0.584	.016	12	view →
TGCT	DFS	Quartile	All	0.971	0.786	.005	12	view →
LGG	DFS	Tertile	All	0.573	0.743	.019	12	view →
BLCA	DFS	Tertile	IV	0.142	0.483	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

NMD3P2–KIRP (OS)

Open the KIRP breakdown →